Strabism. Strabism, unspecified
Conditions
Interventions
Intervention 1: Metoclopramide (Dopamine receptor antagonist used for the treatment of nausea and vomiting) 150?g/kg administered intravenously(at one time) five minutes before induction of general an
Prevention
Metoclopramide (Dopamine receptor antagonist used for the treatment of nausea and vomiting) 150?g/kg administered intravenously(at one time) five minutes before induction of general anesthesia after r
Ondansetron (5HT3 antagonist anti-emetic used for the treatment of nausea and vomiting) 50?g/kg administered intravenously(at one time) five minutes before induction of general anesthesia after routin
Sponsors
Research Vice chancellor of Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
6 Years to 12 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients with average age of 6-12y/o, ASA (American Society of Anesthesiologists) physical status I and II candidated for strabism surgery with general anesthesia Exclusion criteria: The patients who received antiemetics during previous 24 hours, the patients suffering from liver, renal, gastrointestinal disorders and motion sickness
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea. Timepoint: After 0, 2, 6 and 24 hours of surgury. Method of measurement: Zero for not having nausea - 1, for mild nausea- 2, for moderate nausea and 3 for sever nausea. | — |
Secondary
| Measure | Time frame |
|---|---|
| Vomiting. Timepoint: After 0, 2, 6 and 24 hours of surgury. Method of measurement: Zero for the patients not experiencing vomiting, 1 for the little vomiting, 2 for vomiting gastric contents and 3 for vomiting food particles. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Parvar Hassanzadeh Salmasi
Tabriz University of Medical Sciences
Outcome results
None listed